Abstract
The widespread use of imaging has increased the detection of incidental adrenal lesions, most of which are benign and non-functioning adenomas. Discrimination between a benign and malignant adrenal mass significantly impacts treatment and prognosis, especially in oncologic patients. While most adrenal masses have classical imaging findings, there is considerable overlap between benign and malignant lesions; therefore, a thorough understanding of adrenal mass imaging is essential to assist clinicians. The management of these lesions relies on algorithms and multidisciplinary approach, primarily considering findings on dynamic adrenal computed tomography and chemical shift imaging, along with clinical history and symptoms, biochemical workup, and morphological changes of the lesion over time.
Keywords: Adrenal gland, incidentaloma, computed tomography, magnetic resonance imaging, chemical shift imaging
References
Herr K, Muglia VF, Koff WJ, Westphalen AC. Imaging of the adrenal gland lesions.Radiologia Brasileira. 2014;47:228-39.
Schieda N, Siegelman ES. Update on CT and MRI of adrenal nodules.AJR Am J Roentgenol. 2017; 208: 1206-1217.
Glazer DI, Mayo-Smith WW. Management of incidental adrenal masses: an update.Abdom Radiol (NY). 2020; 45: 892-900.
Albano D, Agnello F, Midiri F, Pecoraro G, Bruno A, Alongi P, et al. Imaging features of adrenal masses.Insights Imaging. 2019; 10: 1.
Young WF Jr. Clinical practice. The incidentally discovered adrenal mass.N Engl J Med. 2007; 356: 601-10.
Kapoor A, Morris T, Rebello R. Guidelines for the management of the incidentally discovered adrenal mass.Can Urol Assoc J. 2011; 5: 241-7. Erratum in: Can Urol Assoc J. 2012; 6: 244.
Lattin GE Jr, Sturgill ED, Tujo CA, Marko J, Sanchez-Maldonado KW, Craig WD, et al. From the radiologic pathology archives: adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation.Radiographics. 2014; 34: 805-29.
Shin YR, Kim KA. Imaging features of various adrenal neoplastic lesions on radiologic and nuclear medicine imaging.AJR Am J Roentgenol. 2015; 205: 554-63.
Blake MA, Cronin CG, Boland GW. Adrenal imaging.Am J Roentgenol. 2010; 194: 1450-60.
Bracci B, De Santis D, Del Gaudio A, Faugno MC, Romano A, Tarallo M, et al. Adrenal lesions: a review of imaging.Diagnostics (Basel). 2022; 12: 2171.
Chung R, Garratt J, Remer EM, Navin P, Blake MA, Taffel MT, et al. Adrenal neoplasms: lessons from adrenal multidisciplinary tumor boards.Radiographics. 2023; 43: e220191.
Nandra G, Duxbury O, Patel P, Patel JH, Patel N, Vlahos I. Technical and interpretive pitfalls in adrenal imaging.Radiographics. 2020; 40: 1041-60.
Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.Radiology. 2002; 222: 629-33.
Liu T, Sun H, Zhang H, Duan J, Hu Y, Xie S. Distinguishing adrenal adenomas from non-adenomas with multidetector CT: evaluation of percentage washout values at a short time delay triphasic enhanced CT.Br J Radiol. 2019; 92: 20180429.
Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging.Radiographics. 2001; 21: 995-1012.
Varghese JC, Hahn PF, Papanicolaou N, Mayo-Smith WW, Gaa JA, Lee MJ. MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times.Clin Radiol. 1997; 52: 603-6.
Adam SZ, Nikolaidis P, Horowitz JM, Gabriel H, Hammond NA, Patel T, Yaghmai V, Miller FH. Chemical shift MR imaging of the adrenal gland: principles, pitfalls, and applications.Radiographics. 2016; 36: 414-32.
Sebro R, Aslam R, Muglia V. When is MRI unlikely to characterize an indeterminate adrenal nodule, based on density on an unenhanced CT.Abdominal Radiology Course. 2013.
Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?Radiology. 2004; 231: 711-6.
Miller FH, Wang Y, McCarthy RJ, Yaghmai V, Merrick L, Larson A, et al. Utility of diffusion-weighted MRI in characterization of adrenal lesions.AJR Am J Roentgenol. 2010; 194: W179-85.
Shimizu A, Oriuchi N, Tsushima Y, Higuchi T, Aoki J, Endo K. High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing’s syndrome.Ann Nucl Med. 2003; 17: 403-6.
Sahdev A. Imaging incidental adrenal lesions.Br J Radiol. 2023; 96: 20220281.
Sahdev A, Reznek RH, Evanson J, Grossman AB. Imaging in Cushing’s syndrome.Arq Bras Endocrinol Metabol. 2007; 51: 1319-28.
Rockall AG, Babar SA, Sohaib SA, Isidori AM, Diaz-Cano S, Monson JP, et al. CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome.Radiographics. 2004; 24: 435-52.
Park SY, Park BK, Park JJ, Kim CK. Differentiation of adrenal hyperplasia from adenoma by use of CT densitometry and percentage washout.AJR Am J Roentgenol. 2016; 206: 106-12.
Michelle MA, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, et al. Adrenal cortical hyperplasia: diagnostic workup, subtypes, imaging features and mimics.Br J Radiol. 2017; 90: 20170330.
Lumachi F, Zucchetta P, Marzola MC, Bui F, Casarrubea G, Angelini F, et al. Usefulness of CT scan, MRI and radiocholesterol scintigraphy for adrenal imaging in Cushing’s syndrome.Nucl Med Commun. 2002; 23: 469-73.
Rana AI, Kenney PJ, Lockhart ME, McGwin G Jr, Morgan DE, Windham ST 3rd, et al. Adrenal gland hematomas in trauma patients.Radiology. 2004; 230: 669-75.
Reginelli A, Vacca G, Belfiore M, Sangiovanni A, Nardone V, Vanzulli A, et al. Pitfalls and differential diagnosis on adrenal lesions: current concepts in CT/MR imaging: a narrative review.Gland Surg. 2020; 9: 2331-42.
Jordan E, Poder L, Courtier J, Sai V, Jung A, Coakley FV. Imaging of nontraumatic adrenal hemorrhage.Am J Roentgenol. 2012; 199: W91-W8.
Rozenblit A, Morehouse HT, Amis ES Jr. Cystic adrenal lesions: CT features.Radiology. 1996; 201: 541-8.
Sanal HT, Kocaoglu M, Yildirim D, Bulakbasi N, Guvenc I, Tayfun C, et al. Imaging features of benign adrenal cysts.Eur J Radiol. 2006; 60: 465-9.
Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma.Lancet. 2005; 366: 665-75.
Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, et al. CT and MRI of adrenal gland pathologies.Quant Imaging Med Surg. 2018; 8: 853-75.
Mendiratta-Lala M, Avram A, Turcu AF, Dunnick NR. Adrenal imaging.Endocrinology Metabolism Clinics. 2017; 46: 741-59.
Leung K, Stamm M, Raja A, Low G. Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging.AJR Am J Roentgenol. 2013; 200: 370-8. Erratum in: AJR Am J Roentgenol. 2013; 200: 705.
Kang S, Oh YL, Park SY. Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria.Abdom Radiol (NY). 2021; 46: 1082-90.
Patel J, Davenport MS, Cohan RH, Caoili EM. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?AJR Am J Roentgenol. 2013; 201: 122-7.
Schieda N, Alrashed A, Flood TA, Samji K, Shabana W, McInnes MD. Comparison of quantitative MRI and CT washout analysis for differentiation of adrenal pheochromocytoma from adrenal adenoma.AJR Am J Roentgenol. 2016; 206: 1141-8.
Naji M, AL-Nahhas A.Ga-labelled peptides in the management of neuroectodermal tumours. Eur J Nucl Med Mol Imaging. 2012; 39 (Suppl 1): S61-7.
Velikyan I, Sundin A, Sörensen J, Lubberink M, Sandström M, Garske-Román U, et al. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.J Nucl Med. 2014; 55: 204-10.
Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation.Radiographics. 2002; 22: 911-34.
Scherer A, Niehues T, Engelbrecht V, Mödder U. Imaging diagnosis of retroperitoneal ganglioneuroma in childhood.Pediatr Radiol. 2001; 31: 106-10.
Guo YK, Yang ZG, Li Y, Deng YP, Ma ES, Min PQ, et al. Uncommon adrenal masses: CT and MRI features with histopathologic correlation.Eur J Radiol. 2007; 62: 359-70.
Dong A, Cui Y, Wang Y, Zuo C, Bai Y. (18)F-FDG PET/CT of adrenal lesions.AJR Am J Roentgenol. 2014; 203: 245-52.
Otal P, Escourrou G, Mazerolles C, Janne d’Othee B, Mezghani S, Musso S, et al. Imaging features of uncommon adrenal masses with histopathologic correlation.Radiographics. 1999; 19: 569-81.
Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update.J Clin Endocrinol Metab. 2006; 91: 2027-37.
Else T, Rodriguez-Galindo C. 5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids! Horm Cancer. 2016; 7: 36-9.
Taffel M, Haji-Momenian S, Nikolaidis P, Miller FH. Adrenal imaging: a comprehensive review.Radiol Clin North Am. 2012; 50: 219-43, v.
Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB, et al. Adrenocortical carcinoma: the range of appearances on CT and MRI.AJR Am J Roentgenol. 2011; 196: W706-14.
Panda A, Das CJ, Dhamija E, Kumar R, Gupta AK. Adrenal imaging (Part 1): Imaging techniques and primary cortical lesions.Indian J Endocrinol Metab. 2015; 19: 8-15.
Slattery JM, Blake MA, Kalra MK, Misdraji J, Sweeney AT, Copeland PM, et al. Adrenocortical carcinoma: contrast washout characteristics on CT.AJR Am J Roentgenol. 2006; 187: W21-4.
Ardito A, Massaglia C, Pelosi E, Zaggia B, Basile V, Brambilla R, et al. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.Eur J Endocrinol. 2015; 173: 749-56.
Aziz SA, Laway BA, Rangreze I, Lone MI, Ahmad SN. Primary adrenal lymphoma: differential involvement with varying adrenal function.Indian J Endocrinol Metab. 2011; 15: 220-3.
Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, et al. Adrenal lymphoma: presentation, management and prognosis.QJM: An International Journal of Medicine. 2017; 110: 103-9.
Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review.Ann Hematol. 2013; 92: 1583-93.
Zhang LJ, Yang GF, Shen W, Qi J. Imaging of primary adrenal lymphoma: case report and literature review.Acta Radiol. 2006; 47: 993-7.
Zhou L, Peng W, Wang C, Liu X, Shen Y, Zhou K. Primary adrenal lymphoma: radiological; pathological, clinical correlation.Eur J Radiol. 2012; 81: 401-5.
Leite NP, Kased N, Hanna RF, Brown MA, Pereira JM, Cunha R, et al. Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies.Radiographics. 2007; 27: 1613-34.
Lam KY, Lo CY. Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.Clin Endocrinol (Oxf). 2002; 56: 95-101.
Choi YA, Kim CK, Park BK, Kim B. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.Radiology. 2013; 266: 514-20.
Elsayes KM, Mukundan G, Narra VR, Lewis JS Jr, Shirkhoda A, Farooki A, et al. Adrenal masses: mr imaging features with pathologic correlation.Radiographics. 2004;24 (Suppl 1): S73-86.
Rha SE, Byun JY, Jung SE, Chun HJ, Lee HG, Lee JM. Neurogenic tumors in the abdomen: tumor types and imaging characteristics.Radiographics. 2003; 23: 29-43.
Low G, Dhliwayo H, Lomas DJ. Adrenal neoplasms.Clin Radiol. 2012; 67: 988-1000.
Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, et al. Management of incidental adrenal masses: a white paper of the ACR Incidental Findings Committee.Journal of the American College of Radiology. 2017; 14: 1038-44.
Johnson PT, Horton KM, Megibow AJ, Jeffrey RB, Fishman EK. Common incidental findings on MDCT: survey of radiologist recommendations for patient management.J Am Coll Radiol. 2011; 8: 762-7.
Corwin MT, Schieda N, Remer EM, Caoili EM. Management of incidental adrenal nodules: a survey of abdominal radiologists conducted by the Society of Abdominal Radiology Disease-Focused Panel on Adrenal Neoplasms.Abdom Radiol (NY). 2022; 47: 1360-8.
Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.Endocr Pract. 2009; 15: 450-3.
Vaidya A, Hamrahian A, Bancos I, Fleseriu M, Ghayee HK. The evaluation of incidentally discovered adrenal masses.Endocr Pract. 2019; 25: 178-92.
Cawood TJ, Hunt PJ, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?Eur J Endocrinol. 2009; 161: 513-27.
Corwin MT, Navarro SM, Malik DG, Loehfelm TW, Fananapazir G, Wilson M, et al. Differences in growth rate on CT of adrenal adenomas and malignant adrenal nodules.AJR Am J Roentgenol. 2019; 213: 632-6.
